News
CNXU
7.44
+2.34%
0.17
Conexeu Highlights ECM-Based Regenerative Platform Ahead of 2026 Aesthetics Symposium
TipRanks · 10h ago
Weekly Report: what happened at CNXU last week (0803-0807)?
Weekly Report · 1d ago
Weekly Report: what happened at CNXU last week (0727-0731)?
Weekly Report · 08/03 10:35
Weekly Report: what happened at CNXU last week (0720-0724)?
Weekly Report · 07/27 10:40
Weekly Report: what happened at CNXU last week (0713-0717)?
Weekly Report · 07/20 10:36
Top Biotech Gainers: APLM Climbs 22%; IOVA, RCEL On Watch; MANE Gains On Hair Loss Data
NASDAQ · 07/16 03:41
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga · 07/15 17:05
Weekly Report: what happened at CNXU last week (0706-0710)?
Weekly Report · 07/13 10:38
One Formula, One Platform: Inside the Preclinical Milestone Behind Conexeu's Move Into Medical Aesthetics
Barchart · 07/09 07:16
Conexeu Sciences Targets Tissue Restoration Gap Amid $190 Billion Weight-Loss Boom
NASDAQ · 07/08 07:47
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga · 07/07 17:05
Weekly Report: what happened at CNXU last week (0629-0703)?
Weekly Report · 07/06 10:43
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 07/02 12:05
Weekly Report: what happened at CNXU last week (0622-0626)?
Weekly Report · 06/29 10:36
Conexeu Sciences: Hanging On The FDA 510(k) Pathway Submission
Seeking Alpha · 06/24 07:55
Opening Day: Kardigan races higher after debut on Nasdaq
TipRanks · 06/22 17:30
This Credo Technology Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Benzinga · 06/22 12:37
Conexeu Sciences Price Target Announced at $20.00/Share by HC Wainwright & Co.
Dow Jones · 06/22 11:08
Conexeu Sciences Initiated at Buy by HC Wainwright & Co.
Dow Jones · 06/22 11:08
HC Wainwright & Co. Initiates Coverage On Conexeu Sciences with Buy Rating, Announces Price Target of $20
Benzinga · 06/22 10:58
More
Webull provides a variety of real-time CNXU stock news. You can receive the latest news about CONEXEU SCIENCES INC through multiple platforms. This information may help you make smarter investment decisions.
About CNXU
Conexeu Sciences Inc. is an early-stage medical technology company. The Company is focused on developing regenerative biomaterials that address significant needs in wound care, dentistry, and aesthetics. The Company is focused on providing physicians with device-based solutions for healing, restoring soft tissue, and improving patient outcomes across multiple clinical settings. Its core device candidate, CXU, is a temperature-responsive ECM scaffold formulation intended to transition in-situ to a gel-like extra cellular matrix (ECM) within approximately minutes (Ten-Minute Tissue). The Company operates and manages its business in one operating segment, which is developing and commercializing novel cellular therapies for skin restoration in wound care and aesthetics.